chrisvoncsefalvay/vaers-outcomes huggingface dataset:
9 days after my 1st covid shot, a circular red rash appeared around the injection site.  3 inches .  Did not itch nor was there any pain.  18 hours since I noticed it, it is still present and unchanged.  I also have pain in my left leg..may not be related.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 23-DEC-2014, the patient was vaccinated with ZOSTAVAX lot # J011333, expiration date 13-DEC-2014, subcutaneous (dose and strength were not reported). Secondary and concomitant therapies were not reported. Pharmacist reported that the patient received an expire dose of ZOSTAVAX. No known adverse effects. Additional information has been requested.
Returned 1 hr after receiving H1N1 flu vaccine in left delt. Complaining that her nails on her left hand had blood around the edges. Very minute notice bleeding in corner of nails. Advised to see doctor or ER.
Patient says had sore arm and was really hard around the shot area it was swollen .Pt stated couldn't move arm and was unable to do routine work and exercise
This spontaneous report as received from patient's mother refers to her son who is a male patient of an unknown age. The patient's pertinent medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with first dose of GARDASIL (dose, route and lot number not reported) by an unknown nurse. There were no adverse effects with the first dose of GARDASIL. On an unknown date, the patient was vaccinated with second dose of GARDASIL by an unknown nurse. During the administration process of the second dose of GARDASIL (dose, route and lot number not reported), patient's mother stated that the medication from the vaccine was dripping down her son's arm all the way to his elbow. In addition, patient's mother stated that the vaccine was given 'way to flipping fast'. There was no product quality complaint reported. Patient's mother did not provide any other adverse event information. Additional information has been requested.
Child was given Pfizer COVID vaccine for 5-11 year old rather than for 6 mo-4 year old. Child was age 3  years at the time. No immediate reaction noted. Child presented for second dose on 9/2/22 and adverse event was discovered at that time. Discussed with mother who reported no adverse reaction to the initial dose. Child was given her second dose of the appropriate age group vaccine on 9/2/22.
has been with a multitude of symptoms since receiving Pfizer COVID vaccines, first symptoms was intense epigastric pain which developed 1 wk after first vaccine. Was placed on PPI without significant Improvement. delayed second dose to give body chance to recover. Had upper GI series completed, negative for any acute finings. Still with intermittent exacerbations of abdominal pain despite daily use of PPI and intermittent use of H2blocker.  Has continued to see several specialists and multiple visits to the ER secondary to symptoms after second vaccines.  Symptoms after second vaccine seems to be more cardiovascular and pulmonary in nature.  Reports symptoms seem to be changing over time. Has been with intermittent paresthesia's, heaviness to the extremities, chest pain, palpitations and shortness of breath.  Initial work up with cardiology essentially normal. (Holter monitor study, ekg, and treadmill test) Seen allergist who did V/Q scan to Rule out PE, only perfusion portion completed secondary to pandemic  D-dimer was noted to be elevated- was sent to ER again for STAT imaging which was negative for DVT and PE. They placed her on prednisone for a few days which seemed to help alleviate some of her symptoms for a short period of time. Saw COVID-longhaul specialist for further evaluation/management- PFTs abnormal, unclear cause. Recommended further labs- unknown which ones. Was started on another round of prednisone which only provided minimal relief.  Returned to cardiology who feel she may have secondary inflammatory response post vaccine, going for cardiac MRI to rule out myocarditis/endocarditis.  Leg heaviness and paresthesia's are returning again as is her epigastric pain/abdominal pain. These started about a week after second round of steroids.
Almost 1 mo. ago I had high dose Flu Vac. (no pain at site). However few days later whole arm, L side of back and into palm and fingers began aching. Finally getting better but L. hand still feels like it's asleep and fingers number and tingly still!
I received the first shot on 12/21/20 and experienced an odd side effect...my bottom lip experienced numbness-not the entire lip-just a small portion about the width of a finger on the left side. It was not nearly as intense as a Novocaine shot.   This side effect started the next day and lasted about a day and a half.  I am concerned about getting the next shot with the reported cases of Bells Palsy in clinical trials and need some advice please.  I am due the second shot on 1/11/21.  Thank you.
86 Y/O male was Dx with COVID end of December by his PCP and was given cough syrup for distressing cough. Patient progressively became SOB and worsening cough so came to ER. He was not treated with PO steroids per his wife. ER he was in hypoxic resp failure so was placed on BIPAP/CPAP. Currently he is on CPAP mode ventilation. He has OSA and uses CPAP at home. He has been started on IV dexamethasone and Remdesvir loading. He denies fever but C/O chills. Lactic acid was elevated however decreased to < 2.0 after treatment Procalcitonin is > 3.o. Presented to ED from nursing home 1/11/22.  Re-tested upon arrival to ED on 1/11/22 COVID +  T: 97.9 °F  TMIN: 97.5 °F  TMAX: 98.8 °F  HR: 71  RR: 27  BP: 119/84  SpO2: 95%
Swollen lymph node in my left armpit after the second vaccination. It happened again when I received the Shingles vaccine too. All vaccines were given in my left arm. The swelling went down after 10 days the after the Covid vaccine and it took over 2 weeks for the swelling to go down after the Shingle vaccine.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drug details was reported.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterated that because the facility was unable to download the digital data logger, they would need to treat the issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at that time. It was reported that no adverse reactions were reported by any patient. Reporter confirmed that patients had administered doses while the temperature excursion assessment was ongoing.   This case was linked to MOD-2022-501575 (Patient Link).
Patient describes pain in right hip the night 7/26/12 until following day to the point she could not sleep on side. Also, patient experienced rash in area of injection and itching.
The patient wax?s showing signs of hives at the site of the injection. Vital signs were taken. She was offered Benadryl but ultimately decided to pick up over the counter Benadryl on her way home
Pt received vaccine on 06/17/02. She became symptomatic on 06/26 and broke out with rash systemically on 06/27/02.
Swelling, itching, warmth, redness at injection site started at day 8 and spread through day 12 s/p vaccine (today). No fever or chills.
Itchiness at the site of injection; Redness at the site of injection; Soreness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE PAIN (Soreness at the site of injection) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE PAIN (Soreness at the site of injection). At the time of the report, VACCINATION SITE PRURITUS (Itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE PAIN (Soreness at the site of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
multiple pts vaxed w/in the last few months w/Engerix-B & were determined to be non-responders;
Received DtaP 4/13/05, 4/14 small red, hard, area size of bug bite. 4/15/05 L arm upper arm double size, red, hot, hard, itchy, no fever. Mom at 3:15PM to take to Doctor. Has had cool compresses to arm all day. Motrin. No treatment required.
PT WAS APPREHENSIVE OF RECEIVING THE VACCINE AT THE TIME OF INJECTION.  PT BEGAN TO COMPLAIN OF DIZZINESS AND LEFT-SIDED WEAKNESS.  PUPIL WAS DILATED.  BP 200/140.  SENT TO ER.  FINAL DIAGNOSIS OF VASOVAGAL RESPONSE.
A patient experienced chest palpitations after her first dose; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (A patient experienced chest palpitations after her first dose) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20K) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced PALPITATIONS (A patient experienced chest palpitations after her first dose). On 07-Jan-2021, PALPITATIONS (A patient experienced chest palpitations after her first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
starting in the evening of the day of the vaccine, began  experiencing pain in my left pinky.  The following day (1/20), the pain  was worse leaving me unable to do daily tasks.  It increased through the day at work (1-handed work) to the point of being unable to use 3 fingers without excruciating pain.  On 1/21, saw a neurologist who diagnosed parsonage turner's syndrome due to the covid vaccine.
neutrophils were elevated last week; got sick with a different virus; got sick with a different virus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 14Oct2021 (Lot number: FF8841) as dose 1, single for covid-19 immunisation. Relevant medical history included: "autoimmune issues" (unspecified if ongoing), notes: he has autoimmune issues. The patient's concomitant medications were not reported. The following information was reported: NEUTROPHIL COUNT INCREASED (non-serious) with onset Dec2021, outcome "unknown", described as "neutrophils were elevated last week"; ILLNESS (non-serious), VIRAL INFECTION (non-serious) all with onset 2021, outcome "unknown" and all described as "got sick with a different virus". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: patient received his first Pfizer vaccine (purple cap formula) dose and was supposed to get his 2nd dose on 02Nov2021 but was sick with another illness and did not get it. Patient wanted to know can he still get the second dose. He wanted to know about antibodies being stronger if he get the second dose at 3 weeks vs 12 weeks. It was also reported he got sick with a different virus and wanted to know if he can get the 2nd dose of the Pfizer Covid Vaccine. stated his thing is really that he had spoken to his rheumatologist because he has autoimmune issues and the doctor felt that it is probably fine regarding getting the 2nd dose of the Pfizer Covid vaccine and that is why he is calling and asking if Pfizer has ever studied this or he is kind of like a test subject. stated he does not know his vaccine history or what he had as a child regarding vaccines. He received first dose at hospital research and they had a Pfizer nurse that was administering.  No follow-up attempts are possible. No further information is expected.
right arm soreness; right arm redness; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (right arm soreness) and ERYTHEMA (right arm redness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939904, 015M20A and 030L20AH) for COVID-19 prophylaxis.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, the patient experienced PAIN IN EXTREMITY (right arm soreness) and ERYTHEMA (right arm redness). At the time of the report, PAIN IN EXTREMITY (right arm soreness) and ERYTHEMA (right arm redness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment medications were not reported.   This case was linked to MOD-2022-660549, MOD-2022-660555, MOD-2022-660560, MOD-2022-660563 (Patient Link).
This spontaneous report was received from a licensed practical nurse and refers to unknown number of patients of unknown gender. No information regarding the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On unknown dates, between March 2015 to October 2015, the patients were vaccinated with improperly stored ROTATEQ orally (doses and frequencies were not reported) lot # K010222 and expiration date: 12-DEC-2016 and with improperly stored PROQUAD (human serum albumin (HSA)) (doses, frequencies and route of administration were not reported) lot # K020756 and expiration date: 08-JUN-2016. The vaccines were reconstituted with properly stored sterile diluent (manufacturer unknown). The ROTATEQ vaccines were stored between 47 Fahrenheit degrees (°F) to 77 °F for 46 hours and 30 minutes. The PROQUAD vaccines were stored between 15 °F to 46 °F for 31 hours. There was no previous temperature excursion. The digital data logger was involved in recording the temperature excursion. No adverse effects were reported. No causality assessment was provided by the reporter.
Patient tested positive 9/15/21. ED visit at Hospital 9/16/21, discharged.  Patient returned to ED 9/19/21 and admitted. 9/20/21 COVID test positive. Deceased 9/24/21
A couple of months later I noticed a really itchy scalp, then I noticed a really hard bump under my scalp and it would slowly grow as days progressed. I used my nails to get under to try and bust it and no puss or fluid came out only it split my scalp. Two months later I developed more bumps on my shin and it went up my leg. I seen my medical provider and he mentioned he had no clue what it was and when I get another bump to bring in the little hard "bump" that I squeeze out. I've also noticed that my respiratory system has been very weak and I've been really tired.
Patient broke out in a fine red rash. Physician notified and grandmother instructed to give patient Benadryl.
Patient presented with soreness to left deltoid region, unable to lift arm and the pain was radiating to the upper neck, the pain started the next day and has persisted for >1 month
Felt Odd; Flash of warm/flush; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt Odd) and HOT FLUSH (Flash of warm/flush) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A214) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced FEELING ABNORMAL (Felt Odd) and HOT FLUSH (Flash of warm/flush). At the time of the report, FEELING ABNORMAL (Felt Odd) and HOT FLUSH (Flash of warm/flush) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not included.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: NNI
This case was reported by a consumer via call center representative and described the occurrence of shivering in a 61-year-old female patient who received SHINGRIX for prophylaxis. On 22nd August 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In August 2018, less than a week after receiving SHINGRIX, the patient experienced shivering and injection site bruising. On 22nd August 2018, less than a day after receiving SHINGRIX, the patient experienced fatigue, swelling arm, muscle pain and injection site hemorrhage. On an unknown date, the outcome of the shivering, fatigue, swelling arm, injection site bruising, muscle pain and injection site hemorrhage were recovered/resolved. It was unknown if the reporter considered the shivering, fatigue, swelling arm, injection site bruising, muscle pain and injection site hemorrhage to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient for herself. The patient received SHINGRIX in the left deltoid. She stated that the pharmacist must have hit a blood vessel because there was blood on the BAND-AID and noticed a bruise at the injection site about 3 or 4 days later that lasted about a week. Within 12 hours, she experienced muscle pain (resolved over 3 or 4 days), fatigue (resolved after 36 hours) and swelling in the arm. She also had shivering, but it was very short lived. She felt better 48 hours after receiving the vaccine and stated that the side effects were not bad enough to where she would not get the 2nd vaccine.
took 1st capsule 48 hrs later had diarrhea & nausea; persisted w/diarrhea  5 times on Sunday; took 2nd capsule on Sunday & it cont;
Left leg erythematous, no induration, no fluctuance, slight warm, Probable cellulitis.
11/23/09 Received H1N1 flu mist. 11/23/09 aprox. 8pm - patient felt hot. 9pm - patient developed dry cough, and voice became hoarse. 11/23/09 ED then admitted.  12/1/09 Discharge summary, hospital records received. Service dates 11/23/09 to 11/25/09. Assessment: Allergic reaction. Patient presented with localized swelling of lips/nose/cheeks/dorsum of hands. Hoarseness and mild drooling, cough/throat clearing. Splotching on upper neck and back. Erythema ears, hands. Angioedema.  12/07/09 MR received for DOS 11/20/09 DX: numbness bilateral extremities, transverse myelitis, facial numbness. Pt c/o sore throat, dizziness, muscle aches and numbness s/p H1N1 vaccine. Numbness is in LE, face, mouth, tongue, and body.
Vomiting for 12 hours, diarrhea for 24 hours, headache/migraines for 7 days, body aches for 7 days, extreme fatigue, slept for 28 hours at one time, no appetite, runny nose, fever, chills,.
When I got my flu shot it hurt for a little bit. When I got the shingles shot, it hit me. I had the shakes. I could barely stand, I had to sit on my walker. I couldn't catch my breath. When I came home around 3pm I went to bed and didn't get up for 5 hours and I had the shakes and I was coughing a lot. I called an ambulance to check me out. I was fine but my BP was a little high. I am tired and wore out and can't do anything. I can't keep any food down.
The Moderna Bivalent Vaccine had expired 5-18-2023. Inmate had no signs/ symptoms. And no adverse outcomes to date